What is the role of creatine phosphate in muscle?
Which of the following enzymes does not play a role in the generation of the proton gradient during electron transport?
Which of the following inhibits Complex I of the respiratory chain?
Which of the following is a high-energy compound?
What substrate does the heart utilize for energy at rest?
Which of the following metabolic pathways is exothermic?
What is the net ATP yield when one molecule of pyruvate is completely oxidized to CO2 and H2O?
The malate shuttle is important in which of the following organs?
Which of the following is a physiological uncoupler?
What is the primary source of energy for an athlete during the initial 3 minutes of a running race?
Explanation: ### Explanation **Correct Option: B. Provides instant energy** **Mechanism:** Creatine phosphate (also known as phosphocreatine) serves as a high-energy phosphate reservoir in skeletal muscle and the brain. During the first few seconds of intense muscular activity, ATP stores are depleted almost immediately. The enzyme **Creatine Kinase (CK)** catalyzes the transfer of a phosphate group from creatine phosphate to ADP, regenerating ATP rapidly without the need for oxygen or complex metabolic pathways. This is known as the **Lohmann reaction**. It acts as a "metabolic buffer," maintaining ATP levels until slower processes like anaerobic glycolysis and oxidative phosphorylation can take over. **Analysis of Incorrect Options:** * **A. Helps in gluconeogenesis:** Gluconeogenesis is the synthesis of glucose from non-carbohydrate precursors (like lactate, glycerol, and amino acids), primarily occurring in the liver and kidneys. Creatine phosphate does not serve as a substrate for this pathway. * **C. Involved in action-contraction coupling:** This process refers to the link between the electrical excitation of the muscle fiber and the mechanical contraction, primarily mediated by **Calcium ions ($Ca^{2+}$)** and the troponin-tropomyosin complex, not high-energy phosphates. * **D. Helps in stretch reflex:** The stretch reflex is a neurological feedback loop involving muscle spindles and alpha-motor neurons. It is a physiological response to muscle lengthening, not a metabolic process involving creatine. **High-Yield Clinical Pearls for NEET-PG:** * **Creatine Kinase (CK) Isoenzymes:** CK-MB is a marker for myocardial infarction; CK-MM is elevated in muscle diseases (like Duchenne Muscular Dystrophy); CK-BB is found in the brain. * **Creatinine:** Creatinine is the non-enzymatic breakdown product of creatine phosphate. Its excretion in urine is proportional to total muscle mass and is used as a marker for GFR (Glomerular Filtration Rate). * **Energy Sequence:** ATP (1-2 sec) $\rightarrow$ Creatine Phosphate (5-10 sec) $\rightarrow$ Anaerobic Glycolysis $\rightarrow$ Aerobic Metabolism.
Explanation: ### Explanation The generation of a proton gradient across the inner mitochondrial membrane is the driving force for ATP synthesis (Chemiosmotic Theory). This gradient is created by the pumping of protons ($H^+$) from the mitochondrial matrix into the intermembrane space by specific complexes of the Electron Transport Chain (ETC). **Why Succinate Dehydrogenase is the correct answer:** Succinate dehydrogenase (also known as **Complex II**) is the only complex in the ETC that **does not pump protons**. It transfers electrons from Succinate to FAD, and then to Coenzyme Q. Because the free energy change ($\Delta G$) associated with electron transfer through Complex II is relatively small, it is insufficient to transport protons across the membrane. Consequently, it does not contribute directly to the electrochemical proton gradient. **Analysis of Incorrect Options:** * **NADH oxidase (Complex I):** This complex transfers electrons from NADH to Coenzyme Q and pumps **4 protons** into the intermembrane space. * **Cytochrome b-c1 complex (Complex III):** This complex transfers electrons from reduced Coenzyme Q to Cytochrome c via the Q-cycle, pumping **4 protons**. * **Cytochrome oxidase (Complex IV):** This is the terminal oxidase that transfers electrons to Oxygen (forming water) and pumps **2 protons**. **High-Yield Clinical Pearls for NEET-PG:** * **Dual Role:** Succinate dehydrogenase is the only enzyme that participates in both the **TCA Cycle** and the **Electron Transport Chain**. * **Location:** While most TCA enzymes are in the matrix, Succinate dehydrogenase is embedded in the **inner mitochondrial membrane**. * **P:O Ratio:** Because Complex II bypasses the proton-pumping Complex I, the oxidation of $FADH_2$ yields fewer ATP (~1.5) compared to NADH (~2.5). * **Inhibitor:** Malonate is a classic competitive inhibitor of Succinate dehydrogenase.
Explanation: **Explanation:** The respiratory chain (Electron Transport Chain) consists of five complexes located in the inner mitochondrial membrane. **Complex I (NADH:ubiquinone oxidoreductase)** is responsible for transferring electrons from NADH to Coenzyme Q (Ubiquinone). **Why Piercidin is Correct:** **Piercidin A** is a potent structural analogue of Coenzyme Q. It acts as a competitive inhibitor by binding to the ubiquinone-binding site of Complex I, thereby blocking the transfer of electrons. Other classic inhibitors of Complex I include **Rotenone** (a pesticide), **Amobarbital** (a barbiturate), and **MPTP** (associated with Parkinsonism). **Analysis of Incorrect Options:** * **A. Cyanide:** This is a potent inhibitor of **Complex IV** (Cytochrome c oxidase). It binds to the ferric iron ($Fe^{3+}$) in cytochrome $a_3$, halting the final step of electron transfer to oxygen. * **B. Malonate:** This is a classic competitive inhibitor of **Succinate Dehydrogenase**, which is part of the TCA cycle and constitutes **Complex II**. It competes with the substrate succinate. * **C. Carboxin:** This specifically inhibits **Complex II**. It blocks the transfer of electrons from $FADH_2$ to Coenzyme Q. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Piercidin A, Amobarbital, Guanethidine. * **Complex III Inhibitor:** Antimycin A (blocks electron flow from Cytochrome b to $c_1$). * **Complex IV Inhibitors:** Cyanide, Carbon Monoxide (CO), Azide, $H_2S$. * **Complex V (ATP Synthase) Inhibitor:** Oligomycin (closes the $H^+$ channel). * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (Brown fat), high-dose Aspirin. These increase oxygen consumption but decrease ATP synthesis, dissipating energy as heat.
Explanation: **Explanation:** In biochemistry, **high-energy compounds** are defined as those that release a large amount of free energy (ΔG°' more negative than -30.5 kJ/mol) upon hydrolysis. This energy is typically used to drive endergonic reactions or to synthesize ATP. **1. Why Creatine Phosphate is Correct:** Creatine phosphate (Phosphocreatine) is a high-energy phosphagen found predominantly in muscle and brain tissue. It has a standard free energy of hydrolysis of approximately **-43.1 kJ/mol**, which is significantly higher than that of ATP (-30.5 kJ/mol). It acts as a rapid "energy buffer" by donating its phosphate group to ADP to regenerate ATP during the first few seconds of intense muscular contraction, a reaction catalyzed by **Creatine Kinase (CK)**. **2. Why the Other Options are Incorrect:** * **ADP (Adenosine Diphosphate):** While it contains one high-energy phosphoanhydride bond, it is generally considered the "low-energy" product of ATP hydrolysis in the context of cellular work. * **Glucose-6-phosphate & Fructose-6-phosphate:** These are **low-energy phosphates**. Their ΔG°' of hydrolysis is roughly -13.8 kJ/mol. They are metabolic intermediates in glycolysis but do not possess enough group transfer potential to phosphorylate ADP to ATP. **High-Yield NEET-PG Pearls:** * **Highest Energy Compound:** Phosphoenolpyruvate (PEP) has the highest energy (~ -61.9 kJ/mol), followed by 1,3-Bisphosphoglycerate and Creatine Phosphate. * **The ATP Cycle:** ATP is the "Universal Energy Currency," sitting midway in the energy spectrum, allowing it to act as a donor and receiver of phosphate groups. * **Clinical Correlation:** Serum Creatine Kinase (CK) levels are diagnostic markers for myocardial infarction (CK-MB) and muscular dystrophy (CK-MM).
Explanation: **Explanation:** The cardiac muscle is a metabolic omnivore but exhibits a strong preference for specific substrates depending on the body's physiological state. **1. Why Fatty Acids are Correct:** At rest and under aerobic conditions, the heart derives approximately **60-80% of its energy (ATP) from the β-oxidation of Long-Chain Fatty Acids**. This preference exists because fatty acids are the most energy-dense substrates, providing a steady and high-yield supply of ATP required for the continuous, rhythmic contractions of the myocardium. **2. Analysis of Incorrect Options:** * **Ketone Bodies (B):** While the heart can utilize ketone bodies (acetoacetate and β-hydroxybutyrate), it typically does so only during periods of prolonged starvation or uncontrolled diabetes when blood ketone levels are significantly elevated. * **Glucose (C):** Glucose accounts for only about 20-30% of myocardial energy at rest. However, the heart's reliance on glucose increases significantly during the **post-prandial state** (due to insulin) and during **ischemia/hypoxia**, as anaerobic glycolysis becomes a critical survival mechanism. * **Any of the above (D):** While the heart is flexible, "Fatty Acids" is the specific and primary substrate utilized under normal resting conditions. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Switch:** In the failing heart (Heart Failure), there is often a metabolic shift away from fatty acid oxidation back toward glucose utilization (a fetal-like metabolic profile). * **Ischemia:** During myocardial ischemia, β-oxidation is inhibited due to lack of oxygen, and the heart shifts to anaerobic glycolysis, leading to lactic acid accumulation and potential intracellular acidosis. * **Energy Density:** 1 mole of Palmitate (fatty acid) yields ~106-129 ATP, whereas 1 mole of Glucose yields only 30-32 ATP.
Explanation: **Explanation:** In biochemistry, metabolic pathways are classified based on their energy dynamics and the complexity of the molecules involved. **1. Why Catabolic Pathways are Exothermic:** Catabolic pathways involve the **breakdown** of complex macronutrients (carbohydrates, lipids, and proteins) into simpler end products (CO₂, H₂O, and NH₃). During this process, the chemical bonds of these molecules are broken, releasing stored chemical energy. A portion of this energy is captured as ATP, while the rest is released as heat. Because energy is released into the surroundings, these pathways are strictly **exothermic** (and exergonic). **2. Analysis of Incorrect Options:** * **Anabolic Pathways (Option A):** These are biosynthetic pathways that build complex molecules from simpler precursors (e.g., protein synthesis from amino acids). These processes require an input of energy (usually ATP), making them **endothermic** (and endergonic). * **Amphibolic Pathways (Option C):** These pathways serve a dual purpose, acting as links between anabolic and catabolic processes. The classic example is the **TCA Cycle (Krebs Cycle)**. While it involves energy release, it also provides carbon skeletons for biosynthesis (gluconeogenesis, heme synthesis), so it is not classified purely as exothermic. **High-Yield Clinical Pearls for NEET-PG:** * **ATP:** The "Universal Energy Currency" that couples exothermic catabolism to endothermic anabolism. * **TCA Cycle:** The most important **amphibolic** pathway in the body. * **Metabolic Flux:** Regulated primarily by rate-limiting enzymes (e.g., PFK-1 in glycolysis) to ensure energy production meets cellular demand.
Explanation: To calculate the net ATP yield from the complete oxidation of one molecule of **pyruvate**, we must track its journey through the Link Reaction and the Citric Acid Cycle (TCA). ### **Step-by-Step Calculation:** 1. **Link Reaction (Pyruvate to Acetyl-CoA):** * Catalyzed by the Pyruvate Dehydrogenase (PDH) complex. * Produces **1 NADH**. 2. **TCA Cycle (1 turn per Acetyl-CoA):** * Produces **3 NADH** (at Isocitrate DH, α-Ketoglutarate DH, and Malate DH steps). * Produces **1 FADH₂** (at Succinate DH step). * Produces **1 GTP** (equivalent to 1 ATP) via substrate-level phosphorylation (at Succinyl-CoA Synthetase step). **Total Coenzymes Produced:** 4 NADH + 1 FADH₂ + 1 ATP. **Applying Oxidative Phosphorylation Ratios (P:O Ratios):** According to modern bioenergetics (used in recent NEET-PG patterns): * 1 NADH = 2.5 ATP * 1 FADH₂ = 1.5 ATP * **Calculation:** (4 × 2.5) + (1 × 1.5) + 1 = **12.5 ATP.** --- ### **Analysis of Incorrect Options:** * **B (15):** This was the older calculation based on 1 NADH = 3 ATP and 1 FADH₂ = 2 ATP. Modern biochemistry (Lehninger/Harper) has revised these values downward. * **C (18):** This value does not correspond to any standard metabolic pathway for a single pyruvate molecule. * **D (30):** This is the approximate yield for the complete oxidation of one molecule of **Glucose** (not pyruvate) under aerobic conditions. --- ### **High-Yield Clinical Pearls for NEET-PG:** * **PDH Complex:** Requires five cofactors—**T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **P**antothenic acid (B5), and **L**ipoic acid (**T**ender **R**eeds **N**ever **P**lay **L**oud). * **Arsenic Poisoning:** Inhibits the PDH complex by binding to Lipoic acid, leading to lactic acidosis and decreased ATP production. * **Substrate Level Phosphorylation:** In the TCA cycle, this occurs only at the conversion of **Succinyl-CoA to Succinate**.
Explanation: **Explanation:** The **Malate-Aspartate Shuttle** is a biochemical mechanism used to transport reducing equivalents (NADH) from the cytosol into the mitochondrial matrix, as the inner mitochondrial membrane is impermeable to NADH. **1. Why Option A is correct:** This shuttle is primarily active in the **liver, heart, and kidneys**. In these tissues, the shuttle is highly efficient because it results in the production of **2.5 ATP** molecules per NADH molecule. It involves the reversible conversion of oxaloacetate to malate (via cytosolic malate dehydrogenase), which then enters the mitochondria to regenerate NADH for the Electron Transport Chain (Complex I). **2. Why other options are incorrect:** * **Options B, C, and D:** These are incorrect because **skeletal muscle and the brain** primarily utilize the **Glycerol 3-Phosphate Shuttle**. This shuttle is faster but less energy-efficient, bypassing Complex I and delivering electrons directly to Coenzyme Q via FADH2. This results in only **1.5 ATP** per NADH. The brain and muscles prioritize speed of energy delivery over maximum yield during high metabolic demand. **3. High-Yield Clinical Pearls for NEET-PG:** * **ATP Yield:** Malate-Aspartate Shuttle = 32 ATP per glucose; Glycerol 3-Phosphate Shuttle = 30 ATP per glucose (using old nomenclature: 38 vs 36 ATP). * **Key Enzymes:** Look for **Aspartate Aminotransferase (AST)** and **Malate Dehydrogenase** as the diagnostic markers for this shuttle's function. * **Directionality:** Unlike the Glycerol 3-Phosphate shuttle (which is irreversible), the Malate-Aspartate shuttle is **reversible**, allowing it to function based on the NADH/NAD+ ratio.
Explanation: **Explanation:** The core concept here is the **uncoupling of oxidative phosphorylation**. Normally, the flow of electrons through the Electron Transport Chain (ETC) is "coupled" to ATP synthesis via a proton gradient. Uncouplers dissipate this gradient by allowing protons to leak back into the mitochondrial matrix without passing through ATP synthase. **Why Thermogenin is correct:** **Thermogenin (Uncoupling Protein 1 or UCP1)** is a **physiological (natural) uncoupler** found in the inner mitochondrial membrane of **brown adipose tissue**. It allows protons to re-enter the matrix, bypassing ATP synthase. Instead of capturing energy as ATP, the energy is released as **heat**. This is vital for non-shivering thermogenesis in newborns and hibernating animals. **Why the other options are incorrect:** * **2,4-Dinitrophenol (DNP):** While DNP is a potent uncoupler, it is a **synthetic/chemical uncoupler**, not a physiological one. It was historically used as a weight-loss drug but banned due to fatal hyperthermia. * **Oligomycin:** This is an **inhibitor of ATP synthase (Complex V)**. It blocks the proton channel ($F_0$ subunit), which stops both ATP synthesis and the ETC (due to the buildup of a steep proton gradient). It does not uncouple the process; it arrests it. **High-Yield Clinical Pearls for NEET-PG:** * **Brown Fat vs. White Fat:** Brown fat has a high mitochondrial density and contains UCP1. It is abundant in neonates (axillary and interscapular regions). * **Other Uncouplers:** High doses of **Salicylates (Aspirin)** act as uncouplers, explaining the hyperpyrexia seen in aspirin toxicity. * **Effect of Uncouplers:** They **increase** Oxygen consumption and the rate of the ETC, but **decrease** ATP synthesis, leading to heat production.
Explanation: ### Explanation The primary source of energy for high-intensity exercise lasting between **10 seconds and 3 minutes** is **Muscle Glycogen**. **1. Why Muscle Glycogen is Correct:** During the initial phase of a race, the body requires energy faster than aerobic metabolism can provide. Muscle glycogen undergoes **anaerobic glycolysis**, breaking down into glucose-6-phosphate and then to lactate. This pathway provides a rapid supply of ATP (though less efficient than aerobic oxidation) to sustain high-intensity muscle contractions before the cardiovascular system fully adjusts to oxygen demands. **2. Analysis of Incorrect Options:** * **Creatine Phosphate (CP):** This is the primary source for **ultra-short bursts** of activity (0–10 seconds), such as a 100m sprint or weightlifting. CP stores are depleted almost immediately. * **Free Fatty Acids (FFA):** These are the primary fuel source during **prolonged, low-to-moderate intensity** exercise (e.g., a marathon) or resting states. Beta-oxidation is too slow to meet the energy demands of a 3-minute sprint. * **Blood Glucose:** While used during exercise, it becomes a significant contributor only after muscle glycogen stores begin to deplete or during prolonged steady-state exercise. Uptake from the blood is slower than the breakdown of internal muscle stores. **3. High-Yield NEET-PG Pearls:** * **0–10 seconds:** ATP-CP System (Phosphagen system). * **10 seconds–3 minutes:** Anaerobic Glycolysis (Muscle Glycogen). * **>3 minutes:** Aerobic Metabolism (Oxidation of Glycogen and Fatty Acids). * **Cori Cycle:** During the 3-minute mark, lactate produced in muscles travels to the liver to be converted back to glucose. * **Rate-limiting enzyme of Glycolysis:** Phosphofructokinase-1 (PFK-1), which is activated by AMP during exercise.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free